Clinical Trials Logo

Clinical Trial Summary

Hypothermia with intrajugular cooling is a neuroprotective strategy that has been proven to minimize brain damage and maximize functional preservation in animal models of stroke. The purpose of this proof-of-concept study is to determine the safety and tolerability of intrajugular cooling in patients with acute ischemic stroke who are treated with mechanical thrombectomy.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05488392
Study type Interventional
Source Capital Medical University
Contact Xunming Ji, M.D.
Phone 010-83198952
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date November 1, 2022
Completion date February 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT04069546 - The Efficacy of Remote Ischemic Conditioning on Stroke-induced Immunodeficiency N/A
Recruiting NCT04415164 - Evaluation of Xueshuantong in Patients With AcutE IschemiC STroke Phase 4
Completed NCT05429658 - Single Arm Trial to Evaluate the Safety and Effectiveness of the Route 92 Medical Reperfusion System N/A
Not yet recruiting NCT05390580 - Neuromodulation Using Vagus Nerve Stimulation Following Ischemic Stroke as Therapeutic Adjunct N/A
Recruiting NCT05070260 - Adaptive Efficacy and Safety Study of Glenzocimab Used as an add-on Therapy on Top of Standard of Care un the 4.5 Hours Following an Acute Ischemic Stroke Phase 2/Phase 3
Completed NCT03366818 - New Stent Retriever, VERSI System for AIS N/A
Not yet recruiting NCT04984577 - Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke Phase 2
Completed NCT02223273 - Brazilian Intervention to Increase Evidence Usage in Practice - Stroke (BRIDGE-Stroke) N/A
Completed NCT02586233 - Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic Stroke Phase 1/Phase 2
Not yet recruiting NCT01594190 - Physical Activity Immediately After Acute Cerebral Ischemia N/A
Terminated NCT01694381 - Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor Early Phase 1
Completed NCT01120301 - Efficacy and Safety Trial of Transcranial Laser Therapy Within 24 Hours From Stroke Onset (NEST-3) Phase 3
Completed NCT01021319 - Identification of Stroke Patients ≤ 3 and ≤ 4.5 Hours of Symptom Onset by Fluid Attenuated Inversion Recovery (FLAIR) Imaging and Diffusion Weighted Imaging (DWI)
Completed NCT00963989 - Imaging Guided Patient Selection for Interventional Revascularization Therapy N/A
Recruiting NCT00710164 - Effectiveness and Safety of Xiaoshuanchangrong (XSCR) Capsule for the Treatment of Patients Who Have Suffered From a Stroke Phase 2/Phase 3
Completed NCT00777140 - Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion Phase 2
Recruiting NCT04072705 - Clopidogrel Preventive Effect Based on CYP2C19 Genotype in Ischemic Stroke
Not yet recruiting NCT03669653 - Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Ischemic Stroke N/A
Completed NCT04240470 - Endovascular Stroke Treatment Only (ESTO) Trial N/A
Not yet recruiting NCT04488692 - Early Functional Training in Acute Stroke Inpatient Ward N/A